{"id":"https://openalex.org/W2018007412","doi":"https://doi.org/10.1021/jm030888c","title":"Pyrazole Derivatives as Partial Agonists for the Nicotinic Acid Receptor","display_name":"Pyrazole Derivatives as Partial Agonists for the Nicotinic Acid Receptor","publication_year":2003,"publication_date":"2003-08-01","ids":{"openalex":"https://openalex.org/W2018007412","doi":"https://doi.org/10.1021/jm030888c","mag":"2018007412","pmid":"https://pubmed.ncbi.nlm.nih.gov/12930155"},"language":"en","primary_location":{"id":"doi:10.1021/jm030888c","doi":"https://doi.org/10.1021/jm030888c","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm030888c","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032580119","display_name":"Teunie van Herk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"T. van Herk","raw_affiliation_strings":["Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, P.O. Box 9502, 2300 RA Leiden, The Netherlands, and Institute of Pharmacology, Im Neuenheimer Feld 366, University of Heidelberg, D-69120 Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, P.O. Box 9502, 2300 RA Leiden, The Netherlands, and Institute of Pharmacology, Im Neuenheimer Feld 366, University of Heidelberg, D-69120 Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076010654","display_name":"Johannes Brussee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"J. Brussee","raw_affiliation_strings":["Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, P.O. Box 9502, 2300 RA Leiden, The Netherlands, and Institute of Pharmacology, Im Neuenheimer Feld 366, University of Heidelberg, D-69120 Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, P.O. Box 9502, 2300 RA Leiden, The Netherlands, and Institute of Pharmacology, Im Neuenheimer Feld 366, University of Heidelberg, D-69120 Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034968752","display_name":"Adrianus M. C. H. van den Nieuwendijk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"A. M. C. H. van den Nieuwendijk","raw_affiliation_strings":["Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, P.O. Box 9502, 2300 RA Leiden, The Netherlands, and Institute of Pharmacology, Im Neuenheimer Feld 366, University of Heidelberg, D-69120 Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, P.O. Box 9502, 2300 RA Leiden, The Netherlands, and Institute of Pharmacology, Im Neuenheimer Feld 366, University of Heidelberg, D-69120 Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110264213","display_name":"P. A. M. VAN DER KLEIN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"P. A. M. van der Klein","raw_affiliation_strings":["Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, P.O. Box 9502, 2300 RA Leiden, The Netherlands, and Institute of Pharmacology, Im Neuenheimer Feld 366, University of Heidelberg, D-69120 Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, P.O. Box 9502, 2300 RA Leiden, The Netherlands, and Institute of Pharmacology, Im Neuenheimer Feld 366, University of Heidelberg, D-69120 Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065525958","display_name":"Adriaan P. IJzerman","orcid":"https://orcid.org/0000-0002-1182-2259","observed_orcids":["https://orcid.org/0000-0002-1182-2259"]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"A. P. IJzerman","raw_affiliation_strings":["Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, P.O. Box 9502, 2300 RA Leiden, The Netherlands, and Institute of Pharmacology, Im Neuenheimer Feld 366, University of Heidelberg, D-69120 Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, P.O. Box 9502, 2300 RA Leiden, The Netherlands, and Institute of Pharmacology, Im Neuenheimer Feld 366, University of Heidelberg, D-69120 Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044203510","display_name":"Christina Stannek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"C. Stannek","raw_affiliation_strings":["Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, P.O. Box 9502, 2300 RA Leiden, The Netherlands, and Institute of Pharmacology, Im Neuenheimer Feld 366, University of Heidelberg, D-69120 Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, P.O. Box 9502, 2300 RA Leiden, The Netherlands, and Institute of Pharmacology, Im Neuenheimer Feld 366, University of Heidelberg, D-69120 Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017683993","display_name":"Anja Burmeister","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"A. Burmeister","raw_affiliation_strings":["Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, P.O. Box 9502, 2300 RA Leiden, The Netherlands, and Institute of Pharmacology, Im Neuenheimer Feld 366, University of Heidelberg, D-69120 Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, P.O. Box 9502, 2300 RA Leiden, The Netherlands, and Institute of Pharmacology, Im Neuenheimer Feld 366, University of Heidelberg, D-69120 Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110291848","display_name":"A. Lorenzen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"A. Lorenzen","raw_affiliation_strings":["Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, P.O. Box 9502, 2300 RA Leiden, The Netherlands, and Institute of Pharmacology, Im Neuenheimer Feld 366, University of Heidelberg, D-69120 Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, P.O. Box 9502, 2300 RA Leiden, The Netherlands, and Institute of Pharmacology, Im Neuenheimer Feld 366, University of Heidelberg, D-69120 Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5065525958"],"corresponding_institution_ids":["https://openalex.org/I223822909"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":2.2369,"has_fulltext":false,"cited_by_count":116,"citation_normalized_percentile":{"value":0.85752853,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"46","issue":"18","first_page":"3945","last_page":"3951"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.7113999724388123,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.7113999724388123,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.12300000339746475,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.09390000253915787,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/g-protein-coupled-receptors","display_name":"G protein-coupled receptors","score":0.8019999861717224},{"id":"https://openalex.org/keywords/pyrazoles","display_name":"pyrazole derivatives","score":0.8820000290870667},{"id":"https://openalex.org/keywords/partial-agonists","display_name":"partial agonists","score":0.8740000128746033},{"id":"https://openalex.org/keywords/niacin","display_name":"nicotinic acid","score":0.859000027179718},{"id":"https://openalex.org/keywords/lipid-lowering-drugs","display_name":"lipid-lowering drugs","score":0.9660000205039978},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.7630000114440918},{"id":"https://openalex.org/keywords/skin-flushing","display_name":"skin flushing","score":0.796999990940094},{"id":"https://openalex.org/keywords/receptor-binding-affinity","display_name":"receptor binding affinity","score":0.5920000076293945},{"id":"https://openalex.org/keywords/intrinsic-activity","display_name":"intrinsic activity","score":0.9399999976158142},{"id":"https://openalex.org/keywords/g-protein-activation","display_name":"G protein activation","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9563624858856201},{"id":"https://openalex.org/C2777682936","wikidata":"https://www.wikidata.org/wiki/Q408908","display_name":"Pyrazole","level":2,"score":0.8112667798995972},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.7449599504470825},{"id":"https://openalex.org/C188987157","wikidata":"https://www.wikidata.org/wiki/Q7030581","display_name":"Nicotinic agonist","level":3,"score":0.7029229402542114},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4249325394630432},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.41409575939178467},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4015046954154968},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.36489802598953247},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3284202814102173},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002462","descriptor_name":"Cell Membrane","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009525","descriptor_name":"Niacin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011869","descriptor_name":"Radioligand Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013154","descriptor_name":"Spleen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017667","descriptor_name":"Adipocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018722","descriptor_name":"Nicotinic Agonists","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D018722","descriptor_name":"Nicotinic Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018722","descriptor_name":"Nicotinic Agonists","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D018733","descriptor_name":"Nicotinic Antagonists","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D018733","descriptor_name":"Nicotinic Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018733","descriptor_name":"Nicotinic Antagonists","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D019204","descriptor_name":"GTP-Binding Proteins","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm030888c","doi":"https://doi.org/10.1021/jm030888c","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm030888c","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:12930155","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12930155","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6240000128746033,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W1485967434","https://openalex.org/W1968531334","https://openalex.org/W1973225718","https://openalex.org/W1982891404","https://openalex.org/W1983693956","https://openalex.org/W1988283362","https://openalex.org/W1995683422","https://openalex.org/W1997556546","https://openalex.org/W2050533190","https://openalex.org/W2078894302","https://openalex.org/W2098346876","https://openalex.org/W2952971155","https://openalex.org/W4249545014"],"related_works":["https://openalex.org/W2049582784","https://openalex.org/W2051427616","https://openalex.org/W2072771433","https://openalex.org/W2080754366","https://openalex.org/W2037637780","https://openalex.org/W1982134384","https://openalex.org/W1985018554","https://openalex.org/W2950632471","https://openalex.org/W2044730782","https://openalex.org/W3008595228"],"abstract_inverted_index":{"Nicotinic":[0],"acid":[1,59,86,99,123,127,164,223,239,245],"as":[2],"a":[3,18,45,63,167,180,198,253],"hypolipidemic":[4],"agent":[5],"appears":[6],"unique":[7],"due":[8],"to":[9,12,17,71,88,97,108,155,221,248,252],"its":[10],"potential":[11],"increase":[13],"HDL":[14],"cholesterol":[15],"levels":[16],"greater":[19],"extent":[20],"than":[21],"other":[22],"drugs.":[23],"However,":[24],"it":[25],"has":[26],"some":[27],"side":[28],"effects,":[29],"among":[30],"which":[31],"severe":[32],"skin":[33],"flushing":[34],"is":[35],"the":[36,51,187,194,208,231,249],"most":[37,115,195],"frequent":[38],"and":[39,54,93,111,125,138,179,240],"often":[40],"limits":[41],"patients'":[42],"compliance.":[43],"In":[44,120],"search":[46],"for":[47,50,75],"novel":[48],"agonists":[49],"recently":[52],"identified":[53],"cloned":[55],"G":[56,216],"protein-coupled":[57],"nicotinic":[58,98,156,222,238,244],"receptor,":[60],"we":[61],"synthesized":[62],"series":[64],"of":[65,84,134,141,170,176,184,203,207,215,256],"substituted":[66],"pyrazole-3-carboxylic":[67],"acids":[68],"that":[69],"proved":[70,129],"have":[72],"substantial":[73],"affinity":[74],"this":[76],"receptor.":[77],"The":[78,227],"affinities":[79],"were":[80,100,117],"measured":[81],"by":[82,102,213,224,235],"inhibition":[83,214],"[(3)H]nicotinic":[85],"binding":[87,107],"rat":[89,109],"spleen":[90,112],"membranes.":[91,113],"Potencies":[92],"intrinsic":[94,147,182,201],"activities":[95],"relative":[96,181],"determined":[101],"their":[103,146],"effects":[104],"on":[105],"[(35)S]GTPgammaS":[106],"adipocyte":[110],"Interestingly,":[114],"compounds":[116],"partial":[118],"agonists.":[119],"particular,":[121],"2-diazabicyclo[3,3,0(4,8)]octa-3,8-diene-3-carboxylic":[122],"(4c)":[124],"5-propylpyrazole-3-carboxylic":[126],"(4f)":[128],"active":[130,161,196],"with":[131,166,197],"K(i)":[132,168],"values":[133,140],"approximately":[135,142,151],"0.15":[136],"microM":[137,237],"EC(50)":[139,174],"6":[143],"microM,":[144,172,178],"while":[145],"activity":[148,183,202],"was":[149,162,193,211],"only":[150],"50%":[152],"when":[153],"compared":[154],"acid.":[157],"Even":[158],"slightly":[159],"more":[160],"5-butylpyrazole-3-carboxylic":[163],"(4g)":[165],"value":[169,175],"0.072":[171],"an":[173],"4.12":[177],"75%.":[185],"Of":[186],"aralkyl":[188],"derivatives,":[189],"4q":[190],"(5-(3-chlorobenzyl)pyrazole-3-carboxylic":[191],"acid)":[192],"relatively":[199],"low":[200],"39%.":[204],"Partial":[205],"agonism":[206],"pyrazole":[209],"derivatives":[210],"confirmed":[212],"protein":[217],"activation":[218],"in":[219],"response":[220],"these":[225],"compounds.":[226],"pyrazoles":[228],"both":[229],"inhibited":[230],"maximum":[232],"effect":[233],"elicited":[234],"100":[236],"concentration":[241],"dependently":[242],"shifted":[243],"concentration-response":[246],"curves":[247],"right,":[250],"pointing":[251],"competitive":[254],"mechanism":[255],"action.":[257]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}